---
category: listing
circular_id: c1ff654534e7b978
date: '2025-10-28'
description: BSE announces listing of 1,32,827 equity shares of Dr.Agarwals Eye Hospital
  Ltd. issued on preferential basis to promoters, effective October 29, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={67B6134B-DA62-4BE5-B576-87C02DC779DE}&noticeno=20251028-10&dt=10/28/2025&icount=10&totcount=28&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine preferential allotment to promoters with standard lock-in period;
  limited market impact as shares are locked until 2027
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251028-10&attachedId=
processing:
  attempts: 1
  content_hash: c49073090bf2b8b4
  processed_at: '2025-10-28T12:48:21.346640'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-10-28T10:07:15+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={67B6134B-DA62-4BE5-B576-87C02DC779DE}&noticeno=20251028-10&dt=10/28/2025&icount=10&totcount=28&flag=0
severity: low
source: bse
stocks:
- DRAGARWAL
tags:
- listing
- equity-shares
- preferential-allotment
- promoter-allotment
- lock-in
title: Listing of new securities of Dr.Agarwals Eye Hospital Ltd.
---

## Summary

BSE has approved the listing of 1,32,827 new equity shares of Dr.Agarwals Eye Hospital Ltd. (Scrip Code: 526783) issued to promoters on a preferential basis. The shares will be available for trading from October 29, 2025, with a lock-in period extending until April 29, 2027.

## Key Points

- 1,32,827 equity shares of Rs. 10/- each issued at a premium of Rs. 5,260/-
- Issue price: Rs. 5,270/- per share
- Total issue size: Approximately Rs. 70.05 crores
- Shares issued to promoters on preferential basis
- Trading permitted from October 29, 2025
- Shares rank pari-passu with existing equity shares
- ISIN: INE934C01018
- Distinctive Numbers: 4700001 to 4832827

## Regulatory Changes

No regulatory changes introduced by this circular.

## Compliance Requirements

- Trading members are informed of the new securities listing
- All 1,32,827 shares are subject to mandatory lock-in until April 29, 2027
- Shares cannot be transferred or sold during the lock-in period as per SEBI regulations

## Important Dates

- **Allotment Date**: September 26, 2025
- **Listing Date**: October 29, 2025
- **Lock-in Expiry**: April 29, 2027

## Impact Assessment

**Market Impact**: Minimal immediate market impact as all shares are locked in for 18 months from listing date. The preferential allotment to promoters indicates capital raising for business operations but will not affect free float or trading volumes until lock-in expires. The issue size of approximately Rs. 70 crores suggests moderate capital infusion for the company's expansion or working capital requirements.